Jefferies Financial Group Inc. Relay Therapeutics, Inc. Transaction History
Jefferies Financial Group Inc.
- $10.2 Billion
- Q1 2024
A detailed history of Jefferies Financial Group Inc. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 101,563 shares of RLAY stock, worth $657,112. This represents 0.01% of its overall portfolio holdings.
Number of Shares
101,563
Previous 209,263
51.47%
Holding current value
$657,112
Previous $2.3 Million
63.44%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding RLAY
# of Institutions
188Shares Held
127MCall Options Held
4.2KPut Options Held
1.7K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$181 Million2.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$76.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.8MShares$63.4 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY7.42MShares$48 Million4.98% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.88MShares$44.5 Million0.01% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $778M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...